Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Diamyd Medical AB (DMYDb)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.900 +0.640    +5.68%
11:29:44 - Closed. Currency in SEK ( Disclaimer )
Type:  Equity
Market:  Sweden
ISIN:  SE0005162880 
S/N:  92206366
  • Volume: 247,469
  • Bid/Ask: 11.900 / 11.900
  • Day's Range: 10.860 - 12.260
Diamyd Medical 11.900 +0.640 +5.68%

DMYDb Recent Sentiments

 
This page contains information on users’ sentiments for the Diamyd Medical AB stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 24, 2024 Claes Almeson   10.760 +10.59%
Mar 04, 2024 PETER ANDERSSON   13.840 Mar 29, 2024 @ 10.480 -24.28%
Feb 22, 2024 Claes Almeson   19.840 Mar 15, 2024 @ 14.780 -25.50%
Feb 22, 2024 Robert Anderson   17.960 Mar 15, 2024 @ 14.780 +17.71%
Feb 19, 2024 Andrei Michin   12.540 Mar 15, 2024 @ 14.780 +17.86%
Feb 05, 2024 PETER ANDERSSON   9.740 Mar 01, 2024 @ 14.040 +44.15%
Jan 12, 2024 Andrei Michin   8.050 Feb 02, 2024 @ 9.410 +16.89%
Nov 20, 2023 Andrei Michin   7.090 Nov 30, 2023 @ 7.100 +0.14%
Nov 15, 2023 Josef Haddad   7.130 Dec 08, 2023 @ 6.930 -2.81%
May 11, 2023 Claes Almeson   15.660 Nov 30, 2023 @ 7.100 -54.66%
May 04, 2023 Niklas Magnusson   19.680 Nov 30, 2023 @ 7.100 -63.92%
Apr 14, 2023 Claes Almeson   19.020 May 09, 2023 @ 19.520 +2.63%
Apr 12, 2023 Андрей Мишин   17.840 May 09, 2023 @ 19.520 +9.42%
Apr 12, 2023 Andrei Michin   17.580 May 09, 2023 @ 19.520 +11.04%
Dec 27, 2022 Andrei Michin   14.390 Jan 20, 2023 @ 15.500 +7.71%
Dec 27, 2022 Claes Almeson   13.870 Jan 20, 2023 @ 15.500 +11.75%
Nov 15, 2022 Erkan Tuga   13.520 Dec 09, 2022 @ 15.800 +16.86%
Apr 13, 2022 Andrei Michin   17.500 May 06, 2022 @ 15.900 -9.14%
Mar 11, 2022 Andrei Michin   14.450 Apr 01, 2022 @ 17.900 +23.88%
Feb 01, 2022 Claes Almeson   17.500 Feb 25, 2022 @ 15.250 -12.86%
Jan 18, 2022 Andrei Michin   14.950 Feb 11, 2022 @ 18.720 +25.22%
Jan 04, 2022 Claes Almeson   15.230 Jan 28, 2022 @ 15.230 0.00%
Dec 07, 2021 Claes Almeson   16.390 Dec 31, 2021 @ 14.800 -9.70%
Nov 24, 2021 Andrei Michin   17.280 Dec 17, 2021 @ 14.580 -15.63%
Oct 27, 2021 Lars Gunnarson   18.380 Nov 19, 2021 @ 18.040 -1.85%
Oct 26, 2021 Andrei Michin   18.900 Nov 19, 2021 @ 18.040 -4.55%
Oct 26, 2021 Claes Almeson   18.630 Nov 19, 2021 @ 18.040 -3.17%
Sep 10, 2021 Christian Pedersen   33.340 Oct 01, 2021 @ 24.500 -26.51%
Sep 10, 2021 Claes Almeson   32.060 Oct 01, 2021 @ 24.500 -23.58%
Jul 30, 2021 Anna Nilsson   30.300 Aug 20, 2021 @ 31.000 +2.31%
Jul 02, 2021 Claes Almeson   32.460 Jul 23, 2021 @ 30.120 -7.21%
Jun 23, 2021 Anna Nilsson   30.160 Jul 16, 2021 @ 30.260 +0.33%
Jun 08, 2021 Claes Almeson   32.640 Jul 01, 2021 @ 32.400 -0.74%
May 21, 2021 Claes Almeson   28.280 Jun 02, 2021 @ 37.260 +31.75%
May 11, 2021 Claes Almeson   27.320 May 17, 2021 @ 28.080 +2.78%
May 07, 2021 Claes Almeson   26.220 May 10, 2021 @ 27.980 -6.71%
Apr 14, 2021 Perre Rautio   26.640 Apr 15, 2021 @ 26.300 -1.28%
Mar 29, 2021 Perre Rautio   30.000 Apr 13, 2021 @ 27.100 -9.67%
Mar 02, 2021 Casper Frykman   33.250 Mar 26, 2021 @ 28.850 -13.23%
Feb 22, 2021 Max Dyvermark   25.800 Mar 19, 2021 @ 33.550 +30.04%
Feb 18, 2021 Claes Almeson   25.500 Feb 18, 2021 @ 25.500 0.00%
Feb 01, 2021 Perre Rautio   27.100 Feb 26, 2021 @ 28.050 +3.51%
Jan 18, 2021 Kenneth Hellberg   30.250 Feb 12, 2021 @ 28.300 -6.45%
Jan 14, 2021 Kurt Van Autryve   31.250 Jan 18, 2021 @ 30.250 -3.20%
Jan 14, 2021 Åsa Eriksson   32.700 Feb 05, 2021 @ 25.900 -20.80%
Jan 14, 2021 Toni Fröschl   29.650 Feb 05, 2021 @ 25.900 +12.65%
Dec 18, 2020 Perre Rautio   30.300 Dec 18, 2020 @ 30.300 0.00%
Nov 06, 2020 Robin Blom   35.700 Nov 27, 2020 @ 32.850 -7.98%
Oct 27, 2020 Tapio Leinonen   29.550 Nov 20, 2020 @ 32.500 +9.98%
Oct 09, 2020 Jesper Bryngelsson   39.550 Oct 30, 2020 @ 33.800 +14.54%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DMYDb Comments

Write your thoughts about Diamyd Medical AB
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email